Go Pro
NASDAQ:HSCSW

Heart Test Laboratories 7/22/2026 Earnings Report

Heart Test Laboratories logo
$0.06 -0.01 (-16.64%)
As of 10:51 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Heart Test Laboratories EPS Results

Actual EPS
N/A
Consensus EPS
-$0.66
Beat/Miss
N/A
One Year Ago EPS
N/A

Heart Test Laboratories Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.05 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Heart Test Laboratories Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Heart Test Laboratories Earnings Headlines

A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
See More Heart Test Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Heart Test Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heart Test Laboratories and other key companies, straight to your email.

About Heart Test Laboratories

Heart Test Laboratories (NASDAQ:HSCSW), a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

View Heart Test Laboratories Profile